InsidersTradesSigma
Track the PROVECTUS BIOPHARMACEUTICALS, INC. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €24m. The latest transaction was disclosed on 14 August 2024 (C). Among the most active insiders: Morris Jeffrey Allen. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
PROVECTUS BIOPHARMACEUTICALS, INC. is a biopharmaceutical company focused on developing innovative treatments for cancer and skin diseases. The company is listed on NASDAQ under the symbol PVCT.